EIP named one of Europe's leading patent firms

No items found.
09 July 2019
Tags
Life

EIP has been ranked by the Financial Times in the top tier amongst Europe's leading patent firms, in electronics and in mechanical engineering.

The rating is the result of a joint project by the Financial Times and Statista, which conducted extensive research. A wide-ranging survey was sent to over 10,000 European patent attorneys and experts in the R&D departments of corporations. After analysing the thousands of recommendations received by survey participants, less than 150 firms stood out as the clear winners. The report focuses on innovation and the business of patent attorneys.

The report covers six broad sectors: Chemistry & Pharmaceuticals; Electrical Engineering; Mechanical Engineering; Biotechnology & Food &; and Materials & Nanotechnology, and we are delighted to be ranked as gold for Electrical Engineering and Mechanical engineering; and silver for Biotechnology & Food and Chemistry & Pharmaceuticals.

Related articles

EIP recognsied for strategic leadership in patent law at the Professional Services Management Excellence Awards
26 March 2026
EIP has been recognised with two Professional Services Management Excellence Awards 2026, including Excellence in Strategic Leadership and Best in Theme: Leadership. The awards reflect the firm’s commitment to aligning patent expertise with commercial insight, strengthening leadership across the firm and delivering patent strategy that supports investment, growth and high‑value business decisions.
EIP promotes Callum Docherty to Principal in the US
19 March 2026
EIP is pleased to announce the promotion of Callum Docherty to Principal, recognizing his substantial contribution to the firm’s international patent practice and his leadership within EIP’s growing US team.
EIP announces the promotion of Rob Barker to Partner
12 March 2026
EIP is pleased to announce the promotion of Robert Barker to Partner, recognising his significant contribution to the firm’s Digital, Chemistry, Life Sciences, and multidisciplinary patent practice since joining in 2014.